Table 2.

Summary of evidence of bland transarterial embolization (TAE)

Authors	n	Summary
Kluger, et al. [23] (2014)	25	TACE vs TAE prior to transplantation
		TAE patients were less likely than TACE patients to require 2 procedures (P=0.04)
		Explant tumors were completely necrotic for 36% of TAE patients, 26% of TACE patients
		3 year survival was higher for TAE (78%) than TACE (74%), (P=0.66)
		3 year recurrence free survival rates was TAE (72%) and TACE (68%), P=0.83
Massarweh, et al. [24] (2016)	405	TAE vs TACE
		No significant difference in mean survival (20.1 vs 23.1 months, P=0.84)
		No significant difference in risk of death associated with TAE.
Brown, et al. [25] (2016)	101	Embolization with microspheres alone vs Doxorubicin-Eluting Microspheres
		Similar adverse events in both groups (38% vs 40%, P=0.48)
		No significant difference in RECIST response, median progression free survival and overall survival.